Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 2396-2402 |
Journal | Annals of Oncology |
Volume | 24 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2013 |
A multinational phase II trial of bevacizumab with low-dose interferon-alpha 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
B. Melichar, S. Bracarda, V. Matveev, B. Alekseev, S. Ivanov, A. Zyryanov, R. Janciauskiene, E. Fernebro, P. Mulders, S. Osborne, S. Jethwa, G. Mickisch, M. Gore, R.J.A. van Moorselaar, M. Staehler, N. Magne, J. Bellmunt
Research output: Contribution to journal › Article › Academic › peer-review